Outcome of the Board Meeting held on February 04, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of AG Ventures Limited approved the unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025. On a standalone basis, revenue from continuing operations rose ~20.7% YoY to Rs. 1,110.04 lakhs (vs Rs. 919.89 lakhs in Q3 FY25), and 9M FY26 standalone revenue grew ~50% to Rs. 2,528.07 lakhs with PAT of Rs. 754.22 lakhs. On a consolidated basis, Q3 FY26 revenue stood at Rs. 3,114.40 lakhs (~5% YoY) with PAT of Rs. 224.58 lakhs, while 9M FY26 PAT (continuing) grew ~37% to Rs. 562.03 lakhs. A major one-time exceptional loss of Rs. 37,494.57 lakhs was booked in the prior year related to the demerger of the chemicals business (now shown as discontinued operations). The statutory auditor S S Kothari Mehta & Co. issued an unqualified limited review report. The company also decided to continue under the normal tax regime (not opt for Section 115BAA) and its subsidiary Duncan Engineering incorporated a wholly-owned unit in Saudi Arabia (no capital infused, no operations yet).
For shareholders: operational performance from continuing businesses (Investments & Trading and General Engineering) is healthy with strong revenue and profit growth on a standalone basis. The historic Rs. 37,494.57 lakhs exceptional loss from the chemicals demerger is in the past and no longer a drag on future earnings. The clean auditor review and improved nine-month profitability are supportive, though investors should watch for margin trends and the eventual consolidation impact of the Saudi subsidiary.